Prolonged and dispersed left-ventricular (LV) contraction is present in patients with long-QT syndrome (LQTS). Electrical and mechanical abnormalities appear most pronounced in symptomatic individuals. We focus on the 'electromechanical window' (EMW; duration of LV-mechanical systole minus QT interval) in patients with genotyped LQTS. Profound EMW negativity heralds torsades de pointes in animal models of drug-induced LQTS.
Introduction
The congenital long-QT syndromes (LQTS) are caused by mutations in genes encoding for cardiac ion-channel subunits or ion-channelassociated proteins. To date, at least 15 different genes have been causally implicated. 1 Long-QT syndromes-related ion-channel defects predispose to cardiac action-potential prolongation and accentuate regional and temporal dispersion of repolarization. Genotype-specific pro-arrhythmic conditions can exacerbate repolarization dispersion and lead to the occurrence of afterdepolarizations, premature ventricular ectopic beats, and reentrant excitation. These mechanisms can precipitate torsades de pointes (TdP) in susceptible LQTS patients, but their exact contribution to arrhythmogenesis remains often obscure. Additional mechanisms, including mechano-electrical triggers, appear relevant, but remain to be fully elucidated. 2 There have been reports of altered ventricular mechanics in (subsets of) LQTS patients. Using the M-mode, Nador et al. 3 demonstrated rapid early contraction and an extended phase of LV-wall thickening before rapid relaxation in 55% of LQTS patients, being most overt in symptomatic individuals. In some, mostly symptomatic, patients a peculiar double-peak pattern of LV-wall thickening was observed, possibly the mechanical correlate of early afterdepolarizations. 3 These LQTS-related mechanical abnormalities were normalized by Ca 2+ -channel blocker treatment. 4 Similar results were obtained using tissue-Doppler imaging techniques. 5, 6 Strain-imaging revealed longer contraction duration in the subendocardium than the midmyocardium of symptomatic LQTS-mutation carriers (but less so of asymptomatic or healthy individuals), indicating accentuated transmural mechanical dispersion in the former. 5 Prolonged contraction duration and augmented longitudinal mechanical dispersion were superior to QTc for arrhythmia-risk assessment. 5, 7 Only few studies have addressed indices of electromechanical coupling in LQTS patients. In 1991, Vincent et al. 8 reported on the ratio of electrical to mechanical systole in an ungenotyped RomanoWard family. By measuring QT interval and time from Q-wave to second heart sound (QS 2 ), they demonstrated a prolonged QT/ QS 2 ratio in rest increasing during exercise (1.12 to 1.45) in RomanoWard patients with a resting QTc of 490 ms. In controls, QT/QS 2 increased only modestly from a rest ratio of ,1.0. The relation of QT/QS 2 to major arrhythmic events was not examined. 8 Experimentally, Gallacher et al. 9, 10 demonstrated in anaesthetized dogs that under baseline conditions the LV-pressure duration outlasts both QT interval and LV-endocardial monophasic-actionpotential duration, thus creating a positive so-called 'electromechanical window' (EMW). 10 Electromechanical window turned very negative during pharmacological I Ks block just prior to the induction of TdP by beta-adrenergic stimulation. 9, 10 Within this negative EMW, sizeable LV aftercontractions arose consistently if TdP ensued. This led us to investigate the EMW in a large population of LQTS probands and their asymptomatic genotype-positive family members, under clinically stable conditions. We compared LQTS patients with healthy controls, with and without beta-blocking therapy. All underwent echocardiography with simultaneous standard 3-lead ECG recording to determine the EMW non-invasively. We hypothesized that the EMW is more negative in LQTS patients than in healthy controls, and that profound EMW negativity correlates significantly with major arrhythmic events.
Methods
This study was carried out in accordance with the ethical guidelines of the Declaration of Helsinki. Patients gave written informed consent for DNA diagnostics and echocardiographic research. IRB approval for the retrospective analysis of genotype and echocardiographic phenotype data was provided for the patients evaluated at Mayo Clinic.
Study population
In this case-control, multicentre study, 244 genotype-positive LQTS index cases and asymptomatic family members, and 76 healthy controls were included. A heterozygous KCNQ1 mutation was present in 107 individuals (LQT1), a KCNH2 mutation in 84 (LQT2), a SCN5A mutation in 41 (LQT3), a KCNE1 mutation in 8 (LQT5), a KCNE2 mutation in 1 (LQT6), and double heterozygous mutations (KCNQ1 + KCNH2) in 2 patients. The remaining patient was double heterozygote for KCNQ1 mutations with clinical features of Jervell and Lange-Nielsen syndrome (JLNS). Mutations were considered 'pathogenic' or 'variants of uncertain significance' (VUS) based on literature reports and molecular-genetic assessment. Class-3 VUS-positive patients were included after exclusion of other causative gene mutations. In all probands, the clinical diagnosis of LQTS was made using the Schwartz criteria.
11 Arrhythmic events were scored as syncope, documented ventricular tachyarrhythmia (VT), aborted cardiac arrest, and/or sudden death. We included subjects older than 10 years. The use of antiarrhythmic drugs and history of implantable cardioverter defibrillator (ICD) or pacemaker implantation at the time of echocardiography were noted. If possible, EMW measurements were made prior to the initiation of antiarrhythmic therapy.
The healthy control group is described in detail in Supplementary material online.
Echocardiography
Echocardiographic examinations were performed on a Vivid 7 (General Electric Healthcare, Horten, Norway) or IE33 system (Philips, Eindhoven, The Netherlands) and data were analysed by R.M.A.t.B. and K.H.H., blinded to the patient's diagnosis.
Electromechanical window calculation
Continuous-wave Doppler images in the apical long-axis view assessing the aortic-valve flow and concurrent 3-lead ECG tracings were used for EMW calculations ( Figure 1) . We measured (i) the interval from QRS-onset to the aortic-valve closure midline [Q-onset to aortic-valve closure (QAoC) interval], (ii) QT interval in lead II, for the same beat. The EMW (ms) was calculated by subtracting QT from the QAoC interval. Q-onset to aortic-valve closure incorporates the LV-excitation contraction coupling delay, isovolumetric contraction, and ejection time and is taken as an arbitrary derivative of the duration of LV-mechanical systole. 12 It is generally accepted to measure the QT interval in ECG lead II or any longest QT time at the precordium. Here, we assessed lead II because this is also available in commercial ultrasound systems, whereas precordial ECG recordings are normally not. Hypothetically, a longer precordially derived QT would lead to more profound EMW negativity when QAoC remains unaltered. In 6% of our subjects, the 3-lead-echo-related QT interval could not be determined accurately. Instead, contiguous 12-lead ECG-derived QT was obtained at an equivalent RR interval (≤25 ms difference). Bazett's formula was used to correct QT for heart rate.
Statistical analysis
Continuous data were tested for normality of distribution and depicted as mean + SD. Comparison of means in Gaussian-distributed groups was performed by unpaired Student's t-testing. For non-parametric methods the Mann-Whitney U-test was used. For multiple comparisons, one-way ANOVA was applied. Receiver-operating characteristic (ROC) curve and logistic regression analysis were established to assess predictive accuracy. The optimal cut-off value for EMW at highest accuracy, sensitivity, and specificity for the optimal cut-off value was determined. The area under the curve (AUC) and 95%-confidence interval (CI) were determined for EMW/QTc/QT. Comparison of ROC curves was performed using the DeLong and DeLong method. The net reclassification improvement (NRI) was calculated using the following risk categories for arrhythmic events: low probability of arrhythmic events (,20%), intermediate (20 -60%), high (.60%). The number of patients correctly reclassified when EMW was added to the QTc-based model was determined and from that the NRI was calculated. P-values presented were two-sided and considered significant if ,0.05.
Results

Clinical characteristics
Clinical characteristics of the LQTS population and healthy controls are illustrated in Table 1 . Of the LQTS population 163 (67%) were female and 97 (40%) were classified as 'symptomatic', with 31 having cardiac arrest [documented TdP/ventricular fibrillation (VF) in 23; mean TdP/VF episodes per patient 2.8 + 5.9; electrical storm in six], resulting in death in two. The remaining 66 patients experienced at least one syncopal event, with documented nonsustained (polymorphic) VT in nine. Long-QT syndrome patients had lower mean heart rates (66 + 13 vs. 73 + 14 b.p.m. in controls; P , 0.0001). Forty-one percent of patients were on beta-blocker therapy at the time of echocardiography (for EMW calculation), 23% had been implanted with an ICD, 2% with a pacemaker, and 1 individual had undergone left-cardiac sympathetic denervation. None of the patients was ventricularly paced at the time of investigation. Seventy-five percent harboured a pathogenic mutation in one or more LQTS-related genes, whereas 25% had a VUS, being equally present in symptomatic and event-free subjects. Long-QT syndrome patients had longer QT intervals and QTc compared with controls (QT: 451 + 57 vs. 357 + 29 ms; QTc: 465 + 50 vs. 391 + 27 ms; P , 0.0001), with less exaggerated QTc because of inclusion of asymptomatic mutation-positive relatives (i.e. a representative population at the Cardiogenetics Clinic). Q-onset to aortic-valve closure was significantly longer in LQTS patients (408 + 37 vs. 379 + 31 ms; P , 0.0001). Combined, these parameters led to negative EMWs in 
Electromechanical window and arrhythmic events
Age, gender, and genetic diagnosis were similar for symptomatic and asymptomatic LQTS patients (61 vs. 28% beta-blocker therapy, respectively, at the time of echocardiography; Table 2 ). QT and QTc were longer in the former (QT: 479 + 56 vs. 432 + 49 ms; QTc: 488 + 50 vs. 450 + 44 ms; P , 0.0001). Q-onset to aortic-valve closures were similar in both groups. Consequently, symptomatic LQTS patients had a more negative EMW: 267 + 42 vs. 227 + 41 ms (P , 0.0001; Table 2 and Figure 2 ). Interestingly, when plotting EMW against QTc (Figure 3 ), symptomatic and asymptomatic LQTS patients had more negative EMWs for any given QTc than control subjects, which coincided with a more negative slope of the linear relation and a leftward shift of its crossing of the abscissa. By ROC analysis, EMW proved a better discriminator for arrhythmic events than QTc, with an AUC EMW 0.77 (95% CI, 0.71-0.83), AUC QTc 0.71 (95% CI, 0.65-0.78), and AUC QT 0.74 (95% CI, 0.68-0.81; P ¼ 0.03; Figure 4 ). The optimal cut-off value for EMW with 72% accuracy was 262 ms, identifying symptomatic patients with 84% sensitivity and 54% specificity. Logistic regression analysis identified EMW, QTc, and beta-blocker therapy as univariate predictors of arrhythmic events (Supplementary material online, Table S1 ). After multivariate analysis, EMW (but not QTc) remained an independent predictor [odds ratio for 10-ms EMW decrease 1.25 (95% CI, 1.11-1.40; P ¼ 0.001)]. Adding EMW to QTc in LQTS risk assessment resulted in 12 individuals being correctly reclassified into a higher risk category, when compared with a model without EMW. Seven subjects were incorrectly reclassified into a lower risk category. Similarly, 25 asymptomatic individuals were correctly reclassified into a lower risk category, whereas 13 were incorrectly reclassified into a higher risk category. The NRI was 13.3% (P ¼ 0.03) when adding EMW.
Beta-blocker therapy
In healthy individuals, beta-blocker treatment was associated with longer QAoC despite similar QT/QTc (QAoC: 413 + 42 vs. 379 + 31 ms; P , 0.01; QT: 371 + 42 vs. 357 + 29 ms; P ¼ 0.20; QTc: 377 + 34 vs. 391 + 27 ms; P ¼ 0.06). Consequently, their EMW increased to 43 + 25 ms (P , 0.01). For beta-blocker-treated LQTS subjects, both QT and QAoC were longer than in untreated patients (QT: 470 + 57 vs. 437 + 52 ms; QAoC: 416 + 33 vs. 400 + 32 ms; P , 0.001 for both), rendering the EMW more negative (254 + 51 vs. 236 + 41 ms; P ¼ 0.004). Also, QTc was longer (478 + 53 vs. 457 + 46 ms; P ¼ 0.002). In 26 symptomatic patients, beta-blocker therapy was initiated directly after echocardiography. In 15 of these, mostly LQT1 and LQT5 patients repeat echocardiography confirmed preferential QAoC (over QT) prolongation by the addition of therapy, resulting in a trend towards reduced EMW negativity (EMW preBB 232 + 33 vs. EMW postBB 219 + 33 ms; P ¼ 0.06). In total, 88% of the symptomatic patients of this study were ultimately treated with beta-blockers.
Genotype subgroup analysis
For 107 LQT1, 84 LQT2, and 41 LQT3, averaged QTc was similar (467 + 55, 467 + 47, and 462 + 45 ms; 40, 51, 7% beta-blocker therapy, respectively), Supplementary material online, Table S2 . Q-onset to aortic-valve closure was slightly shorter in LQT3 (LQT3: 394 + 37, LQT1: 413 + 40, LQT2: 409 + 33 ms; P ¼ 0.02), which may be related to shorter RR and QT intervals in this subgroup. Altered I Ks /I Kr -dependent pacemaker activity 13 and imbalanced negative chronotropic therapy may have contributed to this. Electromechanical window negativity was similar for LQT1, LQT2, and LQT3, (243 + 47, 247 + 44, and 237 + 47 ms) with longer QTc and unaltered QAoC in symptomatics, resulting in more profound EMW negativity ( Table 3) . Exclusion of the mexiletine-treated LQT3 patients did not alter these findings significantly.
The double-mutation and JLNS patients had the most profound EMW negativity: 291 + 46 ms (n ¼ 3, all symptomatic). For the remaining 8 KCNE1 (LQT5) and 1 KCNE2 (LQT6)-mutation positive patients, an EMW of 216 + 34 ms was found. Electromechanical window dynamicity in a long-QT syndrome patient with electrical storm
In a SCN5A-mutation-positive female (c.4850-4852delTCT; p.delPhe1617), we determined the EMW serially by means of tissue (TDI) and continuous-wave Doppler imaging during a phase with electrical storm, and after clinical stabilization ( Figure 5 ). Acute TdP suppression was achieved by beta-sympathomimetic treatment with isoproterenol, increasing her heart rate to 87 b.p.m. At that moment, EMW was 283 ms (after 27-ms correction for TDI-derived timing of aortic-valve closure, 14 QTc 538 ms). After interruption of isoproterenol, EMW values deteriorated further to 2163 ms within minutes (QTc 505 ms), followed by the recurrence of TdP. During these very negative EMWs, just prior to TdP, premature ventricular beats arose with mechanical activity initiating earlier than the measurable start of QRS, suggesting a mechanism other than excitation-contraction coupling. 2 The patient was restabilized with isoproterenol and permanent right-atrial pacing after ICD implantation. In the months thereafter her EMW during intrinsic sinus rhythm markedly increased to 250 ms (QTc 508 ms) and no ventricular arrhythmias occurred.
Discussion
The present study focuses on electromechanical coupling in genotyped LQTS patients, particularly the EMW, in relation to major arrhythmic events. Our results demonstrate that the physiological LV electromechanical sequence, in which aortic-valve closure occurs after T-wave completion, is reversed in LQTS. The consequent negative EMW occurs primarily by a prolonged QT interval in the absence of a correspondingly increased QAoC. Interestingly, in LQTS the EMW is more negative for any QTc suggesting repolarization-independent influences. Electromechanical window negativity was most pronounced in patients with documented arrhythmic events and those with double heterozygous mutations (two KCNQ1 + KCNH2; one JLNS). Moreover, it appeared a better and independent discriminator of previous arrhythmic events than QTc. In one case with electrical storm, EMW was dynamic and very negative prior to TdP, but increased significantly after clinical stabilization. Our data confirm that inherited repolarization prolongation and instability are crucial factors for TdP, but they also hint towards the importance of mechano-electric triggers, particularly in symptomatic LQTS patients at instances during their cardiac cycle when mechanical systole has ceased, but repolarization is still ongoing.
2 Diastolic spontaneous Ca 2+ release from the sarcoplasmic reticulum (SR) and mechanical aftercontractions can be pivotal arrhythmogenic factors, particularly when myocardial Ca 2+ load is enhanced, as shown experimentally.
9,15
Interaction of electrical and mechanical systole Likewise, we demonstrated a positive EMW value of 22 + 19 ms in healthy controls, corresponding to a QT/QS 2 ratio of 0.94. 8, 17 In clinical non-LQTS studies, the QT/QS 2 ratio was used to investigate electromechanical coupling at resting heart rate, during adrenergic stimulation, 17 changes in autonomic tone, 12 and in coronary artery disease. 16 In patients with prior myocardial infarction, the presence of QT.QS 2 provided a risk indicator of mortality that was more potent than QTc. 17 In this LQTS study consisting of probands and asymptomatic family members, we observed an average EMW of 243 + 46 ms (QT/QS 2 ratio of 1.10), with symptomatic patients having more negative EMWs for a wide QTc range. We speculate that heterogeneous autonomic innervation 18 and/or sympathetic hyperactivity could provoke EMW negativity by enhanced lusitropy in the presence of QT maladaptation, particularly in LQT1, LQT5, JLNS, or other conditions when cAMP-dependent I Ks cannot be adequately recruited to shorten repolarization. This may also apply to other LQTS genotypes if I Ks is intrinsically weak. In LQT3, increased late Na + current may contribute to electromechanical divergence via altered myocardial Na + and Ca 2+ handling. 19 Interestingly, a shorter QAoC was found to underlie the EMW in LQT3, being even shorter in symptomatic individuals (despite longer QTc). Any of these potential mechanisms requires further investigation. Beta-blockade is more efficacious in preventing recurrence of major arrhythmic events in LQT1 than LQT2 or LQT3 patients. While beta-blockers lend their antiarrhythmic actions primarily by dampening myocardial responses to sympathetic stimuli, shortening of QTc has also been demonstrated, mainly through heart rate slowing with minimal effects on QT. 20 Based on our results in LQTS patients and controls, increased contraction duration and a less negative EMW may confer additional antiarrhythmic protection in LQTS, in line with experimental data.
10
Electromechanical window negativity and pro-arrhythmic proclivity
Pro-arrhythmic aspects of EMW negativity have been evaluated in animal models of drug-induced LQTS. 9, 10, 21 In anaesthetized drug-induced LQT1 dogs, I Ks blockade with HMR1556 or JNJ 303 markedly reduced EMW, but did not evoke TdP. 9,10 Additional beta-adrenergic provocation with isoproterenol, exacerbated EMW negativity (to 2109 ms) and led to the emergence of LV aftercontractions within the window, and subsequent TdP onset. 9 Interventions (e.g. verapamil, esmolol, atenolol) that successfully prevented aftercontractions and/or rendered EMW less negative also prevented TdP. 9, 10, 21 In anaesthetized guinea-pigs, the administration of drugs with documented TdP liability (i.e. quinidine, haloperidol, terfenadine, moxifloxacin, ciprofloxacin, and dofetilide) produced TdP only after substantial EMW negativity (,-50 ms) and infusion of adrenaline. 21 Negative-control compounds did not cause EMW negativity or arrhythmia, even though repolarization prolongation Electromechanical window in long-QT syndrome was observed. TdP was typically preceded by aftercontractions. These aftercontractions, and their relation to TdP, suggest mechanoelectric influences during arrhythmogenesis. 2 
Clinical implications
Along with other reports on the importance of mechanical abnormalities in LQTS, 22 our data indicate that the assessment of electromechanical coupling has added value for arrhythmia-risk analysis. The EMW, an easy-to-obtain parameter, proved a better and independent discriminator than resting QTc in our large LQTS population. A cut-off value of ,262 ms predicted arrhythmic events with 72% accuracy. As such, it may be helpful to assess arrhythmia risk, guide antiarrhythmic maintenance therapy, and facilitate the timing of acute interventions in LQTS.
Limitations
The retrospective study design may have led to potential selection bias and confounding factors, among them possible under-and overestimation of arrhythmic events. Echocardiographic examinations were performed at various times without standardization for diurnal sympathetic modulation of QT/QAoC and potential respiratory-cycle variation. This study did not allow for stratification according to beta-blocker therapy. A prospective cohort should confirm the association between EMW negativity and arrhythmic events, and address EMW dynamics over time.
Conclusions
There is mounting evidence of mechanical abnormalities in LQTS. Their quantitative analysis, besides QTc, has added value for arrhythmia-risk prediction. Using transthoracic echocardiography, we find that LQTS patients have a markedly negative EMW over a wide QTc range, which is most pronounced in those with documented arrhythmic events. In this study population, EMW proves superior to and independent from QTc in discriminating between a LQTS patient's historical arrhythmic events. Hence, we propose to consider this parameter in the clinical management of LQTS patients.
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